BRAF and Miyoshi myopathy: In addition, targeted sequencing also confirmed the absence of clonal BRAF (patient no. 1, 654× depth) and KRAS (patient no. 44, 371× depth) mutations in the paired “negative” samples, further supporting regionally restricted aberrations in MM.